glp-1 obesity drug news today september 15 2025 Oral Pill Delivers Injection-Like Weight Loss Results in Clinical Trials ISPOR 2025: Exploring reasons for

Gastroesophageal reflux disease (GERD) causes up to 25% of chronic sore throats, often worse in the morning due to overnight acid exposure while lying flat

In our conversation earlier this month with Lars Petersen, president and CEO of Fujifilm Biotechnologies, he mentioned the big impact of GLP-1 therapies on domestic manufacturing, along with the US administrations push to enact more tariffs.

& Hunter, D

Unlike colostrum-based immunoglobulins or whey protein fractions, SBI is derived directly from bovine serum providing a highly concentrated, stable, and bioavailable IgG source with the most extensive clinical evidence base of any immunoglobulin ingredient in the gut health space.*

Their results provided the first evidence that GLP-1 physiologically controls appetite as an independent brain function

The risk of birth defects with conception by ART